Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC)
2005 ◽
Vol 23
(16_suppl)
◽
pp. 876-876
◽